Literature DB >> 19301657

Protein components of the microRNA pathway and human diseases.

Marjorie P Perron1, Patrick Provost.   

Abstract

MicroRNAs (miRNAs) are key regulators of messenger RNA (mRNA) translation known to be involved in a wide variety of cellular processes. In fact, their individual importance is reflected in the diseases that may arise upon the loss, mutation or dysfunction of specific miRNAs. It has been appreciated only recently that diseases may also develop when the protein components of the miRNA machinery itself are affected. The core enzymes of the major protein complexes involved in miRNA biogenesis and function, such as the ribonucleases III (RNases III) Drosha and Dicer as well as Argonaute 2 (Ago2), appear to be essential. However, the accessory proteins of the miRNA pathway, such as the DiGeorge syndrome critical region gene 8 (DGCR8) protein, Exportin-5 (Exp-5), TAR RNA binding protein (TRBP) and fragile X mental retardation protein (FMRP), are each related, in various ways, to specific genetic diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19301657      PMCID: PMC2903565          DOI: 10.1007/978-1-60327-547-7_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  96 in total

1.  Modular structure of PACT: distinct domains for binding and activating PKR.

Authors:  G A Peters; R Hartmann; J Qin; G C Sen
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

2.  The carboxy-terminal, M3 motifs of PACT and TRBP have opposite effects on PKR activity.

Authors:  Vishal Gupta; Xu Huang; Rekha C Patel
Journal:  Virology       Date:  2003-10-25       Impact factor: 3.616

3.  MicroRNA genes are transcribed by RNA polymerase II.

Authors:  Yoontae Lee; Minju Kim; Jinju Han; Kyu-Hyun Yeom; Sanghyuk Lee; Sung Hee Baek; V Narry Kim
Journal:  EMBO J       Date:  2004-09-16       Impact factor: 11.598

4.  Crystal structure of A. aeolicus argonaute, a site-specific DNA-guided endoribonuclease, provides insights into RISC-mediated mRNA cleavage.

Authors:  Yu-Ren Yuan; Yi Pei; Jin-Biao Ma; Vitaly Kuryavyi; Maria Zhadina; Gunter Meister; Hong-Ying Chen; Zbigniew Dauter; Thomas Tuschl; Dinshaw J Patel
Journal:  Mol Cell       Date:  2005-08-05       Impact factor: 17.970

5.  A transcription map of the DiGeorge and velo-cardio-facial syndrome minimal critical region on 22q11.

Authors:  W Gong; B S Emanuel; J Collins; D H Kim; Z Wang; F Chen; G Zhang; B Roe; M L Budarf
Journal:  Hum Mol Genet       Date:  1996-06       Impact factor: 6.150

6.  TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing.

Authors:  Astrid D Haase; Lukasz Jaskiewicz; Haidi Zhang; Sébastien Lainé; Ragna Sack; Anne Gatignol; Witold Filipowicz
Journal:  EMBO Rep       Date:  2005-10       Impact factor: 8.807

7.  Molecular cloning and expression analysis of a novel gene DGCR8 located in the DiGeorge syndrome chromosomal region.

Authors:  Aiko Shiohama; Takashi Sasaki; Setsuko Noda; Shinsei Minoshima; Nobuyoshi Shimizu
Journal:  Biochem Biophys Res Commun       Date:  2003-04-25       Impact factor: 3.575

8.  Formation of GW bodies is a consequence of microRNA genesis.

Authors:  Kaleb M Pauley; Theophany Eystathioy; Andrew Jakymiw; John C Hamel; Marvin J Fritzler; Edward K L Chan
Journal:  EMBO Rep       Date:  2006-08-11       Impact factor: 8.807

9.  Oligomerization activity of a double-stranded RNA-binding domain.

Authors:  Edward G Hitti; Nina B Sallacz; Vera K Schoft; Michael F Jantsch
Journal:  FEBS Lett       Date:  2004-09-10       Impact factor: 4.124

10.  Merlin, a tumor suppressor, interacts with transactivation-responsive RNA-binding protein and inhibits its oncogenic activity.

Authors:  Joo Yong Lee; Hongtae Kim; Chung Hun Ryu; Jae Young Kim; Byung Hyune Choi; Young Lim; Pil-Woo Huh; Young-Hoon Kim; Kweon-Haeng Lee; Tae-Youn Jun; Hyung Kyun Rha; Joon-Ki Kang; Chang Rak Choi
Journal:  J Biol Chem       Date:  2004-04-27       Impact factor: 5.157

View more
  34 in total

1.  NF-кB-regulated micro RNAs (miRNAs) in primary human brain cells.

Authors:  Walter J Lukiw
Journal:  Exp Neurol       Date:  2011-11-23       Impact factor: 5.330

Review 2.  Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain.

Authors:  Walter J Lukiw; Peter N Alexandrov
Journal:  Mol Neurobiol       Date:  2012-08       Impact factor: 5.590

Review 3.  Designing highly active siRNAs for therapeutic applications.

Authors:  S Patrick Walton; Ming Wu; Joseph A Gredell; Christina Chan
Journal:  FEBS J       Date:  2010-12       Impact factor: 5.542

Review 4.  The Function of TrophomiRs and Other MicroRNAs in the Human Placenta.

Authors:  Yoel Sadovsky; Jean-Francois Mouillet; Yingshi Ouyang; Avraham Bayer; Carolyn B Coyne
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-15       Impact factor: 6.915

Review 5.  Fragile X-associated tremor/ataxia syndrome (FXTAS): pathology and mechanisms.

Authors:  Paul Hagerman
Journal:  Acta Neuropathol       Date:  2013-06-21       Impact factor: 17.088

Review 6.  Human RNAi pathway: crosstalk with organelles and cells.

Authors:  Sadegh Azimzadeh Jamalkandi; Esmaeel Azadian; Ali Masoudi-Nejad
Journal:  Funct Integr Genomics       Date:  2013-11-07       Impact factor: 3.410

Review 7.  MicroRNAs and the regulation of aldosterone signaling in the kidney.

Authors:  Michael B Butterworth
Journal:  Am J Physiol Cell Physiol       Date:  2015-02-11       Impact factor: 4.249

8.  Pigmy MicroRNA: surveillance cops in Therapies kingdom.

Authors:  Utpal Bhadra; Pradipta Patra; Jagamohan Chhatai; Manika Pal-Bhadra
Journal:  Mol Med       Date:  2016-09-28       Impact factor: 6.354

Review 9.  MicroRNA implications across neurodevelopment and neuropathology.

Authors:  Sabata Martino; Ilaria di Girolamo; Antonio Orlacchio; Alessandro Datti; Aldo Orlacchio
Journal:  J Biomed Biotechnol       Date:  2009-10-13

Review 10.  Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer's disease (AD) and in primary human neuronal-glial (HNG) cells.

Authors:  Yuhai Zhao; Surjyadipta Bhattacharjee; Brandon M Jones; Jim Hill; Prerna Dua; Walter J Lukiw
Journal:  Mol Neurobiol       Date:  2013-11-29       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.